Zealous Therapeutics
Zealous Therapeutics, new drug discovery group with mandate of drug discovery and development led by global Pharma and biotech experienced scientists. Founded in 2013, Zealous Therapeutics, a small molecule drug discovery and development biotech that uses a target-centric approach and classical medicinal chemistry to create new medicines. Zealous Therapeutics has created a premier translational research organization known for prescient target selection and high quality, data-driven discovery project execution. Zealous Therapeutics inspires to be a leader in developing new therapeutic solutions. Our programs seek to ameliorate disease by translating cutting edge discoveries into new medicines. We bring innovation for new drugs for patients with oncological and autoimmune disorders by developing an early-stage discovery projects and developing preclinical candidate. Our global footprint, with headquarters in Singapore expert presence in Singapore, USA, Germany and India, allows us optimum access to global for our portfolio drug discovery and development.
Together we can make a difference and improve patients’ lives. We collaborate with Biotech and Pharmaceuticals and research institutions.
Our promises
Zealous Therapeutics caring with discovery to make life better for people around the world.
Vision
Our commitment is to make life better. We will make a significant contribution to humanity by improving global health.
Mission
Providing meaningful solutions for human diseases.
Value
Innovation, Belief, Quality, Customer Satisfaction